Ventilator associated pneumonia in neonates

Not Applicable

• Conditions: Health Condition 1: J09-J18- Influenza and pneumonia

• Registration Number: CTRI/2019/03/017912
• Lead Sponsor: Amrit Tuteja

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

All inborn and outborn neonates satisfying the following criteria will be included in the study:

1.Who require ventilator support for more than 48hrs duration,

AND

2.Needing change of antibiotic

AND

3.Fulfilling the criteria of VAP as per Neo-KISS protocol

Exclusion Criteria

1.Parents not willing to be a part of the study

2.Major cardiac or pulmonary congenital malformations

3.HIV positive mothers

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Microbiological profile (proportion of various microbes) in Blood culture or Blood PCR in babies with VAP. If blood culture and PCR are negative, ET will be considered to label etiology.Timepoint: Till discharge

Secondary Outcome Measures

Name	Time	Method
1.To evaluate incidence of definite, probable and possible VAP in neonates. <br/ ><br>2.Failure of empiric antibiotic therapy (clinical and mirobiological) <br/ ><br>3.Factors associated with increased risk of VAP in neonates <br/ ><br>4.Clinical signs commonly associated with VAP in neonates <br/ ><br>Timepoint: Till discharge